New You, Inc. Subsidiary ST Brands Enters LOI to Acquire

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
194
New You, Inc. Subsidiary ST Brands Enters LOI to Acquire Leading UK CBD Cosmetics and Edibles Wholesaler, Always Pure Organics

Always Pure Organics is a market leader in UK, Japan, and Europe with estimated $17-20M 2021 revenue and largest “High Street” retailer accounts


CARLSBAD, CA, June 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- New You, Inc. (OTCQB: NWYU) today announced entry of its wholly owned subsidiary, ST Brands, into a non-binding letter of intent (LOI) to acquire 100% ownership of Always Pure Organics Limited (“APO”), a top-three wholesale and white label market leader for a complete portfolio of edible, cosmetic and topical cannabidiol (CBD) products in UK, Europe, and Japan.

Terms include a total purchase price of $130,000,000 for 100% ownership of APO with $10M due upon close and 5 tranches over the subsequent 14 months. New You plans to raise additional funds to finance each tranche of the equity purchase

APO is the primary UK, Europe and Japan distributor for ST Brand’s newly acquired Infinite CBD’s edible gummies, an acquisition completed and announced in May of this year.

A video introduction and discussion with Always Pure Organics management about competitive advantages and strategic approach to gaining and growing CBD market leadership can be found here.

APO is a leading provider of bulk CBD ingredients such as CBD distillate, isolate, and CBG isolate, a manufacturer and white label providers of a full complement of bulk products such as gummies, soft gels, balms, CBD patches, CBD and CBG oils among numerous other products and bespoke formulations for Europe and UK’s leading brands.

Domiciled in Scotland with manufacturing based in Manchester, UK, Always Pure Organics has upwards of 50 full-time employees in sales, administration, manufacturing, and logistics.

APO’s two distribution centers for the UK and European markets ensure they meet the demand and expectations of customers with efficient logistics. They aim to deliver outside of the UK within 3 working days.

APO is awaiting notification by the UK Food Service Agency of expected validation of most of their edible products through the submission of detailed data documenting safety of its products. APO currently has 3 dossiers of separate product categories that have advanced to the “admin check” stage where validation is expected to occur in end of July. Validation of APO’s products is expected to lead to greater market share due to the concurrent invalidation of numerous competitive products.

“Through our recent acquisition of APO supplier, Infinite CBD, we have observed that Always Pure has not compromised in their ambition to achieve market leadership through unsurpassed customer service, efficiency, and product quality,” commented Jason Frankovich, New You Inc.’s executive chairman. “The combination of our global supply and distribution capabilities with their regional network and production is highly complementary.”

“Our ambitious expansion plans require strategic capital and we are excited to be combining forces with ST Brands to help achieve our growth objectives,” stated Gavin Ogilvie, Always Pure Organics’ CEO. “Jason and his team have created an impressive platform for growth.”

Both parties intend to complete the definitive securities purchase agreement within 30 days of the LOI.

About Always Pure Organics

Always Pure Organics is a specialist manufacturer and distributor of cannabis-based products. Our purpose is to accelerate global acceptance of and access to cannabinoids. We aim to delight our business customers by offering the most client-centric experience in the cannabis industry; to support, empower them and maximize their success.

Our products are certified Organic & Bio and are produced under GACP, processed under C-GMP conditions.

About New You, Inc.

New You, Inc. (OTCQB: NWYU) wholly-owned subsidiary, ST Brands Corp, is a holding company of branded assets that create, develop, market, and sell unique and proprietary cannabidiol (“CBD”) products to various segments of the global consumer market.

ST Brands applies financial, operational, branding resource infrastructure to deliver turnkey business services and achieve economies of scale in sourcing, production, packaging, and sales.

The Company seeks to acquire scalable cannabis companies with the potential to become sector leaders in the legal cannabis market. We provide growth capital and expert professional oversight in exchange for stock in their company.

Brands are selected for strong unique selling propositions, strategic value to other portfolio companies and potential for ST Brands’ services to enhance cash flow and/or the asset’s equity value.

Products are sold through several channels, including wholesale to retailers, online direct-to-consumer, and white labeling for branded resellers. ST Brands provides its collection of brands and global resources in market research, brand creation and design, supply chain management with GMP and ISO materials, digital marketing and promotion, all to improve cost efficiency, expedite time to market and maximizing growth in each market.

The Company seeks to capitalize on the scaling challenges facing individual CBD consumer products with solutions to issues including global branding obstacles, supply chain fragmentation, traceability, and compliance.

Safe Harbor Act

Statements in this press release that are not based on historical fact are "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies, and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "could," "seek," "intend," "plan," "goal," "estimate," "anticipate" or other comparable terms. We believe expectations reflected in our forward-looking statements are reasonable, although we cannot guarantee achievements, future results, levels of activity, performance, or other future events. These statements are based on management's current expectations and actual results may differ from these forward-looking statements due to numerous factors, including risks related to our ability to raise additional capital, liquidity, revenue growth, operating results, industry, regulations, technology, and products, any of which could cause us to not achieve some or all of our goals, or cause our previously reported actual results and performance to change or differ from future results, performance, or achievements, including those expressed or implied by such forward-looking statements. You should not place undue reliance on these forward-looking statements. Furthermore, the forward-looking statements contained herein are made as of the date of this press release, and we undertake no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release unless otherwise required by law.

Contact:

info@stbrandsinternational.com

New You Inc. (NWYU) Stock Research Links

NWYU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

NORBIT Secures Significant NOK 120M Defence Order

Updated Category News Views 288

NORBIT Secures Significant NOK 120 Million Defence Order NORBIT has recently made an exciting announcement regarding a significant contract within its segment PIR. The company has been awarded a manufacturing order valued at NOK 120 million from a European client specializing in defence and security. This order is poised for delivery in late 2025 and early 2026, marking a...

Continue Reading
Shareholder Concerns Over BCO, SEM, NATL Transactions

Updated Category News Views 12

Is There Smoke Without Fire in Recent Company Mergers? Well, here we go again. It seems every time deals like these pop up, questions start flying about fairness and insider scoops. The big fish here? The Brink's Company (NYSE:BCO), Select Medical Holdings Corporation (NYSE:SEM), and NCR Atleos Corporation (NYSE:NATL). Halper Sadeh LLC, the investor rights firm, is on a...

Continue Reading
TG Therapeutics Director’s Recent Stock Sale Raises Questions

Updated Category News Views 120

Significant Insider Transaction at TG Therapeutics Recently, an important transaction came to light involving Yann Echelard, Director at TG Therapeutics (NASDAQ:TGTX). The details were revealed through the latest SEC filing. On a given date, Echelard sold 5,000 shares, raising a total of $162,850. Such insider trading can often prompt discussions regarding the company’s...

Continue Reading
Innovative Leadership in Facilities Management Revolutionized

Updated Category News Views 214

MasonMade Ventures Launches to Revamp Facilities Management Serial Entrepreneurs Aim to Disrupt the FM Industry through Innovative Software Solutions and Expert Trades MasonMade Ventures, established by visionary entrepreneurs Joseph Scaretta and Moses Carrasco, is set to change the face of facilities management. This operational holding company focuses on investing in...

Continue Reading
Kyverna Therapeutics Engages Investors at Upcoming Events

Updated Category News Views 136

Kyverna Therapeutics' Upcoming Investor Conferences Kyverna Therapeutics, Inc. (NASDAQ: KYTX), a pioneering clinical-stage biopharmaceutical company committed to innovative cell therapies for autoimmune diseases, is slated to present at a series of significant investor conferences this September. Warner Biddle, the Chief Executive Officer of Kyverna, will be the...

Continue Reading